Plasma Fibrinogen-to-Fractional Exhaled Nitric Oxide Ratio (FFR) as an Emerging Biomarker in Bronchiectasis.

Previous observations from our group pointed out the increasing trend of plasma fibrinogen and a decreasing trend of FeNO with worsening pulmonary function in bronchiectasis [ 25 , 26 ].

also in 25,480 other papers

Differences in Clinical Indicators of Disease Activity and Severity Between Patient Groups Dichotomised Using Fibrinogen, FeNO, and FFR We further dichotomised the entire patient population using fibrinogen, FeNO, and FFR to investigate possibly significant differences in selected clinical indicators of disease activity and severity between the two patient groups.

also in 165 other papers